Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Triamcinolone acetonide injections help regrow hair in alopecia areata patients.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Testosterone reduces, while finasteride enhances, morphine's pain relief.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

JAK inhibitors offer new hope for treating severe alopecia areata.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

ATP helps prevent skin damage from vandetanib by reducing stress.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Intralesional triamcinolone acetonide is the most effective treatment for localized alopecia areata.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Tazarotene gel may be more effective for acne than adapalene gel.

AGA might indicate higher risk for severe COVID-19.

A woman's hair grew back with baricitinib treatment, but she developed a temporary hairy tongue that was treated with regular tongue brushing.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Monocyclic aromatic compounds are important for developing various drugs and treatments.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.